Clinical Trial Update: A Relative Bioavailability Study of Metformin HCL Tablets, 1000 mg Under Fasting Conditions [Phase 1]

View source ↗

Summary

This document reports the completion/update of a Phase 1 relative bioavailability study evaluating Metformin HCl 1000 mg tablets under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• METFORMIN HCL (METFORMIN HYDROCHLORIDE)

Snippet

Sponsor: Sandoz | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED